WASHINGTON, DC—A newly approved drug-coated balloon (DCB) for the treatment of in-stent restenosis (ISR) continues to be safe and effective, with fewer events and repeat interventions compared with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback